SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-24-080270
Filing Date
2024-09-19
Accepted
2024-09-19 16:06:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0215110-424b3_silexion.htm 424B3 25602
2 GRAPHIC image_001.jpg GRAPHIC 12819
  Complete submission text file 0001213900-24-080270.txt   44523
Mailing Address 2 HAMAYAN STREET MODIIN-MACCABIM-REUT L3 7177871
Business Address 2 HAMAYAN STREET MODIIN-MACCABIM-REUT L3 7177871 972-8-6286005
Silexion Therapeutics Corp (Filer) CIK: 0002022416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-282017 | Film No.: 241310482
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)